Ornithine decarboxylase and polyamines in familial adenomatous polyposis

Cancer Research

Volumn 57, Issue 2, 1997, Pages 199-201

  Giardiello, Francis M ^a,b   Hamilton, Stanley R ^a   Hylind, Linda M ^a   Yang, Vincent W ^a   Tamez, Pamela ^a   Casero Jr , Robert A ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ORNITHINE DECARBOXYLASE; POLYAMINE;

ARTICLE; CANCER RISK; COLORECTAL CANCER; CONTROLLED STUDY; ENZYME ACTIVITY; FAMILIAL COLON POLYPOSIS; GENE MUTATION; HUMAN; POLYAMINE SYNTHESIS; PRIORITY JOURNAL;

ADENOMATOUS POLYPOSIS COLI; ADOLESCENT; ADULT; CHILD; COLORECTAL NEOPLASMS; FEMALE; GENOTYPE; HUMANS; MALE; ORNITHINE DECARBOXYLASE; POLYAMINES; PUTRESCINE; SPERMIDINE; SPERMINE; TUMOR MARKERS, BIOLOGICAL;

EID: 0031032313     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Kawakami, Y., Robbins, P. F., Wang, R-F., and Rosenberg, S. A. Identification of tumor regression antigens in melanoma. In: V. T. Devita, S. Hellman, and S. A. Rosenberg (eds.), Important Advances in Oncology, pp. 3-21. Philadelphia: J. B. Lippincott Co., 1996.
2. Wang, R-F., Appella, E., Kawakami, Y., Kang, X., and Rosenberg, S. A. Identification of TRP-2 as a human tumor antigen recognized by cytotoxic T lymphocytes. J. Exp. Med., 184: 2207-2216, 1996.
3. Van Pel, A., van der Brugen, P., Coulie, P. G., Brichard, V. G., Lethe, B., van den Eynde, B., Uyttenhove, C., Renauld, J-C., and Boon, T. Genes coding for tumor antigens recognized by cytolytic T lymphocytes. Immunol. Rev., 145: 229-250, 1995.
4. Kawakami, Y., Eliyahu, S., Delgado, C. H., Robbins, P. F., Rivoltini, L., Topalian, S. L., Miki, T., and Rosenberg, S. A. Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor. Proc. Natl. Acad. Sci. USA, 91: 3515-3519, 1994.
5. Kawakami, Y., Eliyahu, S., Delgado, S. H., Robbins, P. F., Sakaguchi, K., Appella, E., Yannelli, J. R., Adema, G. J., Miki, T., and Rosenberg, S. A. Identification of a human melanoma antigen recognized by tumor-infiltrating lymphocytes associated with in vivo tumor rejection. Proc. Natl. Acad. Sci. USA, 97: 6458-6462, 1994.
6. Kawakami, Y., Eliyahu, S., Sakaguchi, K., Robbins, P. F., Rivoltini, L., Yannelli, J. B., Appella, E., and Rosenberg, S. A. Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2 restricted tumor infiltrating lymphocytes. J. Exp. Med., 180; 347-352, 1994.
7. Kawakami, Y., Eliyahu, S., Jennings, C., Sakaguchi, K., Kang, X-Q., Southwood, S., Robbins, P. F., Sette, A., Appella, E., and Rosenberg, S. A. Recognition of multiple epitopes in the human melanoma antigen gp100 associated with in vivo tumor regression. J. Immunol., 154: 3962-3968, 1995.
8. Cox, A. L., Skipper, J., Chen, Y., Henderson, R. A., Darrow, T. L., Shabanowitz, J., Engelhard, V. H., Hunt, D. F., and Slingluff, C. L., Jr. Identification of a peptide recognized by five melanoma-specific human cytotoxic T cell lines. Science (Washington DC), 264: 716-719, 1994.
9. Rivoltini, L., Kawakami, Y., Sakaguchi, K., Southwood, S., Sette, A., Robbins, P. F., Marincola, F. M., Salgaller, M. L., Yennelli, J. R., Appella, E., and Rosenberg, S. A. Induction of tumor reactive CTL from peripheral blood and tumor infiltrating lymphocytes of melanoma patients by in vitro stimulation with an immunodominant peptide of the human melanoma antigen MART-1. J. Immunol., 154: 2257-2265, 1995.
10. Salgaller, M. L., Afshar, A., Marincola, F. M., Rivoltini, L., Kawakami. Y., and Rosenberg, S. A. Recognition of multiple epitopes in the human melanoma antigen gp100 by peripheral blood lymphocytes stimulated in vitro with synthetic peptides. Cancer Res., 55: 4972-4979, 1995.
11. Bakker, A. B. H., Marland, G., de Boer, A. J., Huijbens, R. J. F., Danen, E. H. J., Adema, G. J., and Figdor, C. G. Generation of antimelanoma cytotoxic T lymphocytes from healthy donors after presentation of melanoma-associated antigen-derived epitopes by dendritic cells in vitro. Cancer Res., 55: 5330-5334, 1995.
12. Parkhurst, M. R., Salgaller, M. L., Southwood, S., Robbins, P. F., Sette, S., Rosenberg, S. A., and Kawakami, Y. Improved induction of melanoma reactive CTL with peptides from melanoma antigen gp100 modified at HLA*0201 binding residues. J. Immunol., 757: 2539-2548, 1995.
13. Kozono, H., White, J., Clements, J., Marrack, P., and Kappler, J. Production of soluble MHC class II proteins with covalently bound single peptides. Nature (Lond.), 369: 151-154, 1994.
14. Mottez, E., Langlade-Dmoyen, P., Courier, H., Martinon, F., Maryanski, J., Kourilsky, P., and Abstado, J-P. Cells expressing a major histocompatibility complex class I molecule with a single covalently bound peptide are highly immunogenic. J. Exp. Med., 181: 493-502, 1995.
15. Kawakami, Y., Rosenberg, S. A., and Lotze, M. T. Interleukin-4 promotes the growth of tumor-infiltrating lymphocytes cytotoxic for human autologous melanoma. J. Exp. Med., 168: 2183-2191, 1988.
16. Madden, D. R., Gorga, J. C., Strominger, L., and Willey, D. C. The st.ructure of HLA-B27 reveals nonamer self-peptides bound in an extended conformation. Nature (Lond.), 353: 321-325, 1991.
17. Zhang, W., Young, A. C., Imarai, M., Nathenson, S. G., and Sacchettini, J. C. Crystal structure of the major histocompatibility complex class I H-2Kb molecule containing a single viral peptide: implications for peptide binding and T-cell receptor recognition. Proc. Natl. Acad. Sci. USA, 89: 8403-8407, 1992.
18. Bednarak, M. A., Sauma, S. Y., Gammon, M. C., Porter, G., Tamhankar, S., Williamson, A. R., and Zweerink, H. J. The minimum peptide epitope from the influenza virus matrix protein: extra and intracellular loading of HLA-A2. J. Immunol., 147: 4047-4053, 1991.